Inhibition of CDK9 sensitizes multidrug resistant ovarian cancer cells to paclitaxel
Jinglu Wang(Peking University), Zhenfeng Duan(Sylvester Comprehensive Cancer Center)
Cited by 0
Related Papers
Novel strategies to prevent the development of multidrug resistance (MDR) in cancer
|Oncotarget|2017|208
Targeting Cdk11 in osteosarcoma cells using the CRISPR‐cas9 system
|Journal of Orthopaedic Research®|2014|106
Targeting <i>ABCB1 (MDR1)</i> in multi-drug resistant osteosarcoma cells using the CRISPR-Cas9 system to reverse drug resistance
|Oncotarget|2016|88
The emerging roles and therapeutic potential of cyclin-dependent kinase 11 (CDK11) in human cancer
|Oncotarget|2016|74
SD-1029 Inhibits Signal Transducer and Activator of Transcription 3 Nuclear Translocation
|Clinical Cancer Research|2006|67